SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0000912057-02-041341
Filing Date
2002-11-07
Accepted
2002-11-07 16:13:50
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-4 a2091478zs-4.htm S-4 2062695
3 EXHIBIT 5.1 a2091478zex-5_1.txt EX-5.1 4229
4 EXHIBIT 8.1 a2091478zex-8_1.txt EX-8.1 7061
5 EXHIBIT 8.2 a2091478zex-8_2.txt EX-8.2 5550
6 EXHIBIT 10.48 a2091478zex-10_48.txt EX-10.48 10321
7 EXHIBIT 10.49 a2091478zex-10_49.txt EX-10.49 10357
8 EXHIBIT 23.1 a2091478zex-23_1.txt EX-23.1 696
9 EX-23.4 a2091478zex-23_4.txt EX-23.4 1588
10 EXHIBIT 23.5 a2091478zex-23_5.txt EX-23.5 1107
12 G1043021.JPG g1043021.jpg GRAPHIC 6856
  Complete submission text file 0000912057-02-041341.txt   2113012
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

IRS No.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-101078 | Film No.: 02812721
SIC: 2835 In Vitro & In Vivo Diagnostic Substances